Drug nucleic acid interactions

Gespeichert in:
Bibliographische Detailangaben
Format: Buch
Sprache:English
Veröffentlicht: San Diego [u.a.] Acad. Press 2001
Schriftenreihe:Methods in enzymology 340
Schlagworte:
Online-Zugang:Inhaltsverzeichnis
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000nam a2200000 cb4500
001 BV013874286
003 DE-604
005 20020819
007 t|
008 010822s2001 xx ad|| |||| 00||| eng d
020 |a 0121822419  |9 0-12-182241-9 
035 |a (OCoLC)231881623 
035 |a (DE-599)BVBBV013874286 
040 |a DE-604  |b ger  |e rakwb 
041 0 |a eng 
049 |a DE-20  |a DE-355  |a DE-19  |a DE-91G  |a DE-29T  |a DE-12  |a DE-703  |a DE-188  |a DE-578  |a DE-B768 
084 |a WC 4355  |0 (DE-625)148096:  |2 rvk 
084 |a WD 5050  |0 (DE-625)148185:  |2 rvk 
084 |a CHE 860f  |2 stub 
084 |a MED 970f  |2 stub 
245 1 0 |a Drug nucleic acid interactions  |c ed. by Jonathan B. Chaires ... 
264 1 |a San Diego [u.a.]  |b Acad. Press  |c 2001 
300 |a XXXIV, 705 S.  |b Ill., graph. Darst. 
336 |b txt  |2 rdacontent 
337 |b n  |2 rdamedia 
338 |b nc  |2 rdacarrier 
490 1 |a Methods in enzymology  |v 340 
650 0 7 |a Arzneimittel  |0 (DE-588)4003115-9  |2 gnd  |9 rswk-swf 
650 0 7 |a Nucleinsäuren  |0 (DE-588)4172117-2  |2 gnd  |9 rswk-swf 
650 0 7 |a Wechselwirkung  |0 (DE-588)4064937-4  |2 gnd  |9 rswk-swf 
655 7 |0 (DE-588)4143413-4  |a Aufsatzsammlung  |2 gnd-content 
689 0 0 |a Arzneimittel  |0 (DE-588)4003115-9  |D s 
689 0 1 |a Nucleinsäuren  |0 (DE-588)4172117-2  |D s 
689 0 2 |a Wechselwirkung  |0 (DE-588)4064937-4  |D s 
689 0 |5 DE-604 
700 1 |a Chaires, Jonathan B.  |e Sonstige  |4 oth 
830 0 |a Methods in enzymology  |v 340  |w (DE-604)BV000000938  |9 340 
856 4 2 |m HBZ Datenaustausch  |q application/pdf  |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009491114&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA  |3 Inhaltsverzeichnis 
943 1 |a oai:aleph.bib-bvb.de:BVB01-009491114 

Datensatz im Suchindex

DE-BY-TUM_call_number 0302 CHE 825f 03.1955 A 741
DE-BY-TUM_katkey 1219182
DE-BY-TUM_location 03
DE-BY-TUM_media_number 040030077284
DE-BY-UBR_call_number 88/WC 4355 C719
DE-BY-UBR_katkey 3194791
DE-BY-UBR_location 88
DE-BY-UBR_media_number 069030976774
_version_ 1822682349639303168
adam_text Table of Contents Contributors to Volume 340 ix Preface xiii Volume in Series xv Section I. Biophysical Approaches 1. Analysis and Interpretation of Ligand DNA Jonathan B. CHAIRES 3 Binding Isotherms 2. Surface Plasmon Resonance Biosensor Tina M. Davis and Analysis of RNA Small Molecule W. David Wilson 22 Interactions 3. Simultaneous Measurement of Binding Steven M. Zeman and Constants and Unwinding Angles Donald M. Crothers 51 by Gel Electrophoresis 4. Linear and Circular Dichroism of MAGDALENA ERIKSSON AND Drug Nucleic Acid Complexes BENGT Norden 68 5. Rapid Screening of Structurally Selective JlNSONG Ren and Ligand Binding to Nucleic Acids JONATHAN B. CHAIRES 99 6. Calorimetric Techniques in the Study of Ihtshamul Haq, High Order DNA Drug Interactions BABUR Z. Chowdhry, and Terence C. Jenkins 109 7. Volume Changes Accompanying Interaction LUIS A. MARKY, of Ligands with Nucleic Acids DONALD W. KuPKE, and Besik I. Kankia 149 8. Calculating Sequence Dependent Melting ALBERT S. Benight, Stability of Duplex DNA Oligomers and PETR PANCOSKA, Multiplex Sequence Analysis by Graphs RICHARD OWCZARZY, Peter M. Vallone, Jaroslav Nesetril, and Peter V. Riccelli 165 V Vi TABLE OF CONTENTS 9. Thermal Denaturation as Tool to Study Charles H. Spink and DNA Ligand Interactions SUSAN E. WELLMAN 193 10. Kinetics of Binding of Hoechst Dyes to DNA SOPHIA Y. BREUSEGEM, Studied by Stopped Flow Fluorescence FRANK G. LOONT1ENS, Techniques PETER REGENFUSS, AND Robert M. Clegg 212 11. Scanning Force Microscopy of Nucleic PETER T. LlLLEHEI AND Acid Complexes Lawrence A. Bottomley 234 12. Nuclear Magnetic Resonance Studies of ANDREW N. LANE 252 Drug DNA Complexes in Solution 13. X Ray Crystallography of DNA Drug Mary ELIZABETH PEEK AND Complexes Loren Dean Williams 282 14. Molecular Modeling of Drug DNA JOHN O. TRENT 290 Complexes: An Update Section II. Chemical and Molecular Biological Approaches 15. Peptide Nucleic Acid Targeting of PETER E. NIELSEN 329 Double Stranded DNA 16. Drug Interaction with Triple Helical Nucleic CHRISTOPHE ESCUDE, Acids THERESE GARESTIER, AND Jian Sheng Sun 340 17. Measurement of Covalent Drug DNA Inter Claire J. McGurk, actions at the Nucleotide Level in Cells at Peter J. McHUGH, Pharmacologically Relevant Doses Michael J. Tilby, Keith A. Grimaldi, and John A. Hartley 358 18. Targeting DNA through Covalent Interactions David E. Graves 377 of Reversible Binding Drugs 19. Chemical Cross Linking of Drugs to DNA RYAN A. LUCE AND Paul B. Hopkins 396 20. High Resolution Footprinting Studies of KEITH R. FOX AND Drug DNA Complexes Using Chemical Michael J. Waring 412 and Enzymatic Probes 21. Drug RNA Footprinting Mark P. McPlKE, Jerry Goodisman, and James C. Dabrowiak 431 TABLE OF CONTENTS vii 22. Footprinting Methods for Analysis of JOHN W. Trauger AND Pyrrole Imidazole Polyamide/DNA Peter B. Dervan 450 Complexes 23. High Resolution Transcription Assay for DON R. Phillips, Probing Drug DNA Interactions at SUZANNE M. CUTTS, Individual Drug Sites CARLEEN M. Cullinane, and Donald M. Crothers 466 24. Use of DNA Molecules Substituted with CHRISTIAN Bailly and Unnatural Nucleotides to Probe Specific MICHAEL J. Waring 485 Drug DNA Interactions 25. Drug Interactions with Nucleosomes and JOSE PORTUGAL 503 Chromatin 26. Locating Cobalt Binding Sites on DNA ANGELA M. SNOW AND Using Restriction Endonucleases RICHARD D. SHEARDY 519 27. Exploiting Anthracycline Scaffold for WALDEMAR PRIEBE, Designing DNA Targeting Agents Izabela Fokt, Teresa Przewloka, Jonathan B. Chaires, Jose Portugal, and John O. Trent 529 28. Design, Synthesis, and Characterization VLADIMIR M. GUELEV, of Polyintercalating Ligands Mark S. Cubberley, Meredith M. Murr, R. Scott Lokey, and Brent L. Iverson 556 Section III. Enzymology and Biological Approaches 29. Targeting Telomeres and Telomerase DAEKYU SUN AND Laurence H. Hurley 573 30. Rapid, High Throughput Engineering of Mark ISALAN and Sequence Specific Zinc Finger YEN CHOO 593 DNA Binding Proteins 31. DNA Relaxation and Cleavage Assays to CHRISTIAN Bailly 610 Study Topoisomerase I Inhibitors 32. In Vitro Human Immunodeficiency Virus CHRISTOPHE MARCHAND, Type 1 Integrase Assays Nouri Neamati, and Yves Pommier 624 viii TABLE OF CONTENTS 33. Use of Xenopus Egg Extracts to Study Effects ASMITA KUMAR, of DNA Binding Drugs on Chromatin HONGZHI Xu, and Assembly, Nuclear Assembly, and DNA GREGORY H. LENO 634 Replication Author Index 655 Subject Index 689
any_adam_object 1
building Verbundindex
bvnumber BV013874286
classification_rvk WC 4355
WD 5050
classification_tum CHE 860f
MED 970f
ctrlnum (OCoLC)231881623
(DE-599)BVBBV013874286
discipline Chemie / Pharmazie
Biologie
Medizin
format Book
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01754nam a2200433 cb4500</leader><controlfield tag="001">BV013874286</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20020819 </controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">010822s2001 xx ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0121822419</subfield><subfield code="9">0-12-182241-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)231881623</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV013874286</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-20</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-91G</subfield><subfield code="a">DE-29T</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-703</subfield><subfield code="a">DE-188</subfield><subfield code="a">DE-578</subfield><subfield code="a">DE-B768</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WC 4355</subfield><subfield code="0">(DE-625)148096:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WD 5050</subfield><subfield code="0">(DE-625)148185:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">CHE 860f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 970f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Drug nucleic acid interactions</subfield><subfield code="c">ed. by Jonathan B. Chaires ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">San Diego [u.a.]</subfield><subfield code="b">Acad. Press</subfield><subfield code="c">2001</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXXIV, 705 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Methods in enzymology</subfield><subfield code="v">340</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Nucleinsäuren</subfield><subfield code="0">(DE-588)4172117-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Wechselwirkung</subfield><subfield code="0">(DE-588)4064937-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Nucleinsäuren</subfield><subfield code="0">(DE-588)4172117-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Wechselwirkung</subfield><subfield code="0">(DE-588)4064937-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chaires, Jonathan B.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Methods in enzymology</subfield><subfield code="v">340</subfield><subfield code="w">(DE-604)BV000000938</subfield><subfield code="9">340</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&amp;doc_library=BVB01&amp;local_base=BVB01&amp;doc_number=009491114&amp;sequence=000002&amp;line_number=0001&amp;func_code=DB_RECORDS&amp;service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-009491114</subfield></datafield></record></collection>
genre (DE-588)4143413-4 Aufsatzsammlung gnd-content
genre_facet Aufsatzsammlung
id DE-604.BV013874286
illustrated Illustrated
indexdate 2024-12-23T15:43:08Z
institution BVB
isbn 0121822419
language English
oai_aleph_id oai:aleph.bib-bvb.de:BVB01-009491114
oclc_num 231881623
open_access_boolean
owner DE-20
DE-355
DE-BY-UBR
DE-19
DE-BY-UBM
DE-91G
DE-BY-TUM
DE-29T
DE-12
DE-703
DE-188
DE-578
DE-B768
owner_facet DE-20
DE-355
DE-BY-UBR
DE-19
DE-BY-UBM
DE-91G
DE-BY-TUM
DE-29T
DE-12
DE-703
DE-188
DE-578
DE-B768
physical XXXIV, 705 S. Ill., graph. Darst.
publishDate 2001
publishDateSearch 2001
publishDateSort 2001
publisher Acad. Press
record_format marc
series Methods in enzymology
series2 Methods in enzymology
spellingShingle Drug nucleic acid interactions
Methods in enzymology
Arzneimittel (DE-588)4003115-9 gnd
Nucleinsäuren (DE-588)4172117-2 gnd
Wechselwirkung (DE-588)4064937-4 gnd
subject_GND (DE-588)4003115-9
(DE-588)4172117-2
(DE-588)4064937-4
(DE-588)4143413-4
title Drug nucleic acid interactions
title_auth Drug nucleic acid interactions
title_exact_search Drug nucleic acid interactions
title_full Drug nucleic acid interactions ed. by Jonathan B. Chaires ...
title_fullStr Drug nucleic acid interactions ed. by Jonathan B. Chaires ...
title_full_unstemmed Drug nucleic acid interactions ed. by Jonathan B. Chaires ...
title_short Drug nucleic acid interactions
title_sort drug nucleic acid interactions
topic Arzneimittel (DE-588)4003115-9 gnd
Nucleinsäuren (DE-588)4172117-2 gnd
Wechselwirkung (DE-588)4064937-4 gnd
topic_facet Arzneimittel
Nucleinsäuren
Wechselwirkung
Aufsatzsammlung
url http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009491114&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
volume_link (DE-604)BV000000938
work_keys_str_mv AT chairesjonathanb drugnucleicacidinteractions